Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 806 results for "eli lilly"

FDA approves Eli Lilly's combination drug for metastatic color...

Singapore: US Food and Drug Administration has approved Eli Lilly's ramucirumab (Cyramza) for use in combination with Folfiri, chemotherapy regimen for colorectal cancer, for the treatment of patients with metastatic colorectal cancer (mCRC). ... Bio Spectrum Asia, 1 day ago

272 images for eli lilly

SleekMoney, 2 days ago
BioSpace, 3 days ago
Dallas Morning News, 3 days ago
Benzinga.com, 1 week ago
Sacramento Bee, 3 weeks ago
Pharma Letter, 4 days ago
SPi World News, 3 days ago
Mideast Time, 1 month ago
American Banking News - Forex, 1 month ago
Pharmaceutical Online, 1 week ago

Eli Lilly and Company wins fourth US FDA approval for CYRAMZA for treating metastatic colorectal cancer

Pharmaceutical company Eli Lilly and Company (NYSE:LLY) reported on Friday the receipt of the fourth US Food and Drug Administration (FDA) approval for CYRAMZA (ramucirumab) for treating metastatic colorectal cancer, a cancer that develops in the ...
 BusinessWeek1 day ago
Pharma Letter

FDA approves Cyramza for use with FOLFIRI in second-line treatment of metastatic colorectal cancer

Eli Lilly and Company has received its fourth U.S. Food and Drug Administration (FDA) approval for Cyramza (ramucirumab). Cyramza is now also indicated in combination with FOLFIRI chemotherapy for the treatment of patients with metastatic ...
 European Pharmaceutical Review1 day ago Lilly Cancer Treatment Lands New Approval  Inside INdiana Business1 day ago Lilly Reports First-Quarter 2015 Results  FierceBiotech1 day ago FDA clears new indication for Lilly's Cyramza  Seeking Alpha3 days ago
[x]  

Eli Lilly net earnings fall sharply by 27% to $529 mn in Q1

Eli Lilly & Co has suffered heavy setback during the first quarter ended March 2015 due to unfavorable foreign exchange rates and patent expirations in respect of Cymbalta and Evista. Though its net sales declined by one per cent to $4,645 million ...
 PharmaBiz4 days ago Eli Lilly posts 1Q profit, results beat Wall Street estimates  FOXBusiness.com5 days ago Eli Lilly Q1 Profit Down; Cuts FY15 EPS View - Quick Facts  RTTNews.com5 days ago Lilly Reports Lower Quarterly Profit  Inside INdiana Business5 days ago
[x]  

Eli Lilly (LLY) Trading Near $74.01 Resistance Level

MarketIntelligenceCenter.com's patented algorithms have selected a trade on Eli Lilly and Co (http://www.marketintelligencecenter.com/symbol/LLY"LLY) that returns 8.23% in 56 days for an annualized return rate of 54%. This diagonal spread pairs a ...
 Individual.com3 days ago Eli Lilly (LLY) Crosses Pivot Point Resistance at $72.55  Comtex SmarTrend5 days ago Eli Lilly (LLY) Showing Bullish Technicals With Support At $71.68  Individual.com1 week ago Eli Lilly (LLY) Showing Resistance Near $73.52  Individual.com6 days ago
FOXNews.com

Eli Lilly And Co (LLY) Psoriatic Arthritis Drug Emerges Successful In Phase III Study

Eli Lilly and Co ( NYSE:LLY ) has yet another victory to add to its already established success story; the company on Monday announced that its investigational psoriatic arthritis (PsA) drug met the primary endpoints of a late-stage study. The ...
 Bidness Etc1 week ago Lilly reports positive results from Phase III trial of ixekizumab to treat psoriatic arthritis  Pharmaceutical Business Review1 week ago Eli Lilly and Co (LLY) Q1 Profits Beat Expectations On Rising Sales Of New Drugs And Higher US Prices  Bidness Etc4 days ago Eli Lilly and Co (LLY) Updates FY15 Earnings Guidance  WKRB News4 days ago
[x]  

India has third-highest number of obese people: Study.auac{position:absolute;clip:rect(405px,auto,auto,456px);}eli lilly cialis online

NEW DELHI: India has the third-highest number of obese and overweight people (11 percent of adolescents, and 20 percent of all adults) after US and China, a recent study mapping global malnutrition trends has revealed. The Malnutrition Mapping ...
 Asia Insurance Post1 week ago Asian re/insurance market to gain from ASEAN integration.auac{position:absolute;clip:rect(405px,auto,auto,456px);}eli lilly cialis online  Asia Insurance Post1 week ago Energy insurers need to increase innovation:Willis.auac{position:absolute;clip:rect(405px,auto,auto,456px);}eli lilly cialis online  Asia Insurance Post1 week ago
Pharma Letter

Bristol-Myers Squibb to transfer Erbitux North American rights to Eli Lilly

Eli Lilly and Company and Bristol-Myers Squibb Company have collaborated to transfer rights to the cancer therapy, Erbitux, in North America, including the US, Canada, and Puerto Rico, from Bristol-Myers Squibb to Lilly. Rights include, but are not ...
 Individual.com5 days ago Lilly, BMS Restructure Erbitux (Cetuximab) Collaboration in North America  CPhI.cn1 week ago Lilly, Bristol-Myers Squibb Update Erbitux (cetuximab) Collaboration in North America  Individual.com1 week ago Bristol-Myers Squibb Company announces transfer of full commercialisation rights to Eli Lilly and Company for Erbitux (cetuximab)  Bloomberg1 week ago
[x]  

Eli Lilly Profit Beats Views as Animal Health Shares Shine

Eli Lilly and Co reported a better-than-expected adjusted quarterly profit, helped by a jump in sales of its animal health products, and reaffirmed its adjusted full-year forecast. The Indianapolis-based drugmaker posted a net profit of $529.5 ...
 FOXBusiness.com5 days ago UPDATE 1-Lilly profit beats estimates as animal health sales shine  CNBC5 days ago Lilly 1st-qtr profit beats estimates, helped by cost cuts  Sharenet5 days ago UPDATE 3-Lilly profit beats estimates, helped by cost cuts  Reuters UK5 days ago
[x]  

Eli Lilly earnings reflect new cancer medication sales increase

Eli Lilly has reported first-quarter earnings that beat analysts estimates as the company increased sales of new medications such as cancer drug Cyramza and benefited from higher US prices. Adjusted earnings per share rose to 87 cents, beating ...
 Irish Times5 days ago Eli Lilly Earnings Beat Estimates on New Drugs and Higher Prices  Bloomberg5 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - eli lilly
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less